Skip to main content
. Author manuscript; available in PMC: 2015 Oct 7.
Published in final edited form as: J Med Chem. 2015 Aug 11;58(16):6359–6367. doi: 10.1021/acs.jmedchem.5b00102

Table 2.

Binding Assay Results of N-Methylated Ac-Nle4-c[Asp5,d-Nal(2′)7,Lys10]-NH2 Analogues at hMCRsa

hMC1R hMC3R hMC4R hMC5R

# sequence IC50, nM Bind-Effic IC50, nM Bind-Effic IC50, nM Bind-Effic IC50, nM Bind-Effic
1 Nle D H DNal(2′) R W K 8.7±0.9 100 3.74±0.5 97 2.4±0.2 98 6.9±1.2 98
2 Nle D H DNal(2′) R W K 12.6±1.8 100 23±4 97 18.2±2.1 97 6.1±1.1 98
3 Nle D H DNal(2′) R W K 192±20 77 20.4±3 77 16.2±2 70 16.8±2.3 77
4 Nle D H DNal(2′) R W K 1.4±0.15 90 47.4±5.2 95 6.35±1.0 90 3.41±0.6 96
5 Nle D H DNal(2′) R W K 18.7±0.30 80 27.4±2.1 90 1390±310 90 27.7±3.4 90
6 Nle D H DNal(2′) R W K 106±21 90 3.2±0.5 90 65.9±10 90 5±0.8 90
7 Nle D H DNal(2′) R W K 175±20 86 17.8±2 95 111±13 89 15±1.8 94
8 Nle D H DNal(2′) R W K 3.9±0.5 80 1.6±0.1 90 1010±1.1 90 6±1.0 90
9 Nle D H DNal(2′) R W K 3110±456 82 795±90 90 1380±110 101 95±10 87
10 Nle D H DNal(2′) R W K 196±16 90 24.9±2.1 99 134±15 90 13±0.12 90
11 Nle D H DNal(2′) R W K 111±20 89 19.7±2 93 59.4±6 89 16.46±2.1 93
12 Nle D H DNal(2′) R W K 916±120 92 412±60 92 32.2±5 88 2260±230 72
13 Nle D H DNal(2′) R W K 1050±116 88 3660±410 95 244±31 90 91±9 86
14 Nle D H DNal(2′) R W K 4.9±0.9 90 65±11 90 507±120 90 35.2±5 90
15 Nle D H DNal(2′) R W K 4.0±0.7 90 15.3±2.8 80 98±4.1 90 6.33±0.9 90
16 Nle D H DNal(2′) R W K 2520±320 86 547±70 80 1700±340 90 1670±300 90
17 Nle D H DNal(2′) R W K 246±45 80 9.7±1.2 90 203±7 80 6.66±1 90
18 Nle D H DNal(2′) R W K 246±24 80 147±23 90 549±150 90 592±70 80
19 Nle D H DNal(2′) R W K 242±32 74 106±13 90 100±8 79 268±31 91
20 Nle D H DNal(2′) R W K 256±35 84 8±11 86 722±81 81 39.7±5 90
21 Nle D H DNal(2′) R W K 16.7±2.2 9 2.5±06 94 3.96±1 76 2.82±0.8 90
22 Nle D H DNal(2′) R W K 824±1 00 68 13.7±2 38 8740±841 59 388±41 70
23 Nle D H DNal(2′) R W K 1330±200 70 2220±242 61 99.9±10 36 159±19 67
24 Nle D H DNal(2′) R W K 9.4±1.2 86 51±9 78 1070±110 76 871±91 84
25 Nle D H DNal(2′) R W K 1740±210 68 988±110 90 505±111 67 571.5±61 93
26 Nle D H DNal(2′) R W K 1070±189 93 336±42 82 787±82 68 115±13 92
27 Nle D H DNal(2′) R W K 1220±123 94 1270±210 92 188±21 37 1510±159 32
28 Nle D H DNal(2′) R W K 9.9±1.2 93 20±3 88 0.5±0.02 64 8.1±1 89
29 Nle D H DNal(2′) R W K 1460±163 42 1670±193 97 304±35 27 4290±521 64
30 Nle D H DNal(2′) R W K 1380±150 87 6050±985 93 1790±190 24 1050±120 24
31 Nle D H DNal(2′) R W K 181 0±210 89 657±76 94 949±85 8 177±21 75
32 Nle D H DNal(2′) R W K 68.4±8 91 5820±200 84 3140±270 19 257±34 37
a

Amino acids with N-methyl groups are highlighted in gray. IC50, concentration of peptide at 50% specific binding (N = 4). NB, 0% 125I-NDP-α- MSH displacement observed at 10 µM. Percent binding efficiency, maximal % of 125I-NDP-α-MSH displacement observed at 10 µM.